Skip to content

Trial of padmadi siddha ghrita and dashamuladi ghritapan in Computer Vision Syndrome

Randomized controlled clinical trial of padmadi siddha ghrita aschyotana and dashamuladi ghritapan in Computer Vision Syndrome - Nil

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055090
Enrollment
102
Registered
2023-07-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H041- Other disorders of lacrimal gland

Interventions

None listed

Sponsors

Dr Sumedha Yogesh Kotangale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. The patients between 18 to 50 years of age. 2. Patients using computer more than 2 hrs/day and more than 1 month. 3. Patients having any three clinical features of Computer Vision Syndrome - Blurred vision, Eye Strain, Redness, Burning Sensation, Dry Eye, Excessive fatigue.

Exclusion criteria

Exclusion criteria: 1. Individuals having eye diseases like acute/chronic/infective conjunctivitis, any specific eyelid disorder, Dacryocystitis, Lagophthalmos, Diabetic retinopathy, Nystagmus, Glaucoma,Corneal diseases, Sjogrens Syndrome, Vitamin A deficiency. 2. Patients suffering from known systemic diseases like HIV, Carcinoma, Bleeding disorders, any other infectious and chronic diseases. 3. Individuals having H/O any eye surgery within last 6 months. 4. Lactating, nursing mothers and individuals having fish allergy.

Design outcomes

Primary

MeasureTime frame
Decrease in severity and duration sign and symptoms of Computer Vision Syndrome Timepoint: 15 days

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Chandana Abhay Virkar

PDEAs Ayurved College

drvirkarchandana@gmail.com09822199107

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026